Clinical trial
INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer
NCT00008255 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00008255 |
|---|---|
| Title | INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer |
| Official title | Evaluation Of Uridine 5-Triphosphate Solution For Inhalation (UTP) As An Adjunct In The Diagnosis Of Lung Cancer By Sputum Cytology |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Other |
| Interventions | INS316, sputum cytology |
| Start date | Aug 1, 2000 |
| Completion | May 1, 2004 |
| First posted | May 5, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: